PGI23 Cost Effectiveness of Retreatment of Patients with Chronic Hepatitis C (Chc) Who Do Not Respond to Peginterferon Alpha and Ribavirin for 48 Weeks Vs. Peginterferon Alfa and Ribavirin for 72 Weeks
Abstract
Authors
M. Fonseca G. Tannus E. Parisi